PoSciDonDAO Unveils a Decentralized Future for Personalized Medicine Research
Panama City, Panama, December 12th, 2024, Chainwire PoSciDonDAO, an emerging organization in the Decentralized Science (DeSci) domain, has announced the launch...


Panama City, Panama, December 12th, 2024, Chainwire
PoSciDonDAO, an emerging organization in the Decentralized Science (DeSci) domain, has announced the launch of a decentralized autonomous organization (DAO) dedicated to funding personalized medicine research. Leveraging blockchain technology, PoSciDonDAO aims to improve efficiencies and transparency in research funding while enabling global collaboration to address life-altering diseases such as cancer, multiple sclerosis, and Alzheimer’s disease.
A Vision for Advancing Patient Care
Personalized medicine, which tailors treatments to patients based on genetic and molecular profiles, offers a path toward more effective therapies and better patient outcomes. This field has been hindered by limited funding and systemic inefficiencies. PoSciDonDAO’s mission is to address these challenges by providing resources to explore novel approaches such as viro-immunotherapies and gene and cell therapies.
By funding early-stage, pre-patented research, PoSciDonDAO seeks to drive innovation from academic labs to commercial viability. This initiative is designed to improve healthcare outcomes for patients worldwide by advancing patient-tailored therapies and making innovative treatments more accessible.
Empowering Community Governance
PoSciDonDAO introduces incentive models to foster long-term engagement among scientists, innovators, and DeSci enthusiasts. Its governance framework enables community members to actively participate in DAO operations and funding decisions, ensuring resources are allocated to projects aligned with the shared goal of advancing personalized medicine.
Building Partnerships in Decentralized Science
Since its inception, PoSciDonDAO has been an active participant in Decentralized Science discussions and collaborations. Notably, it engages with other DeSci initiatives such as the Health Data Alliance, which includes projects like AxonDAO, DataLake, and Hippocrat, underscoring its commitment to advancing the DeSci movement. More partnerships and collaborations will be announced in the near future.
About PoSciDonDAO
By combining blockchain technology with scientific innovation, PoSciDonDAO is establishing a collaborative platform for research in personalized medicine. This approach aims to accelerate discoveries and democratize access to resulting treatments, benefiting patients and healthcare systems globally. The PoSciDonDAO team includes experts in virology, immunology, oncology, epidemiology, and Web3. With in-house expertise and contributions from its community members, the DAO can identify which projects have the most potential to impact the personalized medicine field.
The PoSciDonDAO token (SCI) is central to the DAO’s governance model, allowing community members to participate in decision-making processes. This decentralized and transparent mechanism ensures resources are directed toward impactful research projects.
For more information about PoSciDonDAO, users can visit the official PoSciDonDAO website.
Joining the Community
PoSciDonDAO offers scientists, innovators, and DeSci enthusiasts to become part of this transformative initiative. By advancing research in personalized medicine, PoSciDonDAO aims to contribute to improved therapies and better outcomes for patients worldwide.
Twitter/X | Telegram | Discord
Disclaimer
The information provided herein is for informational or educational purposes only and does not constitute financial, legal, or tax advice. Any purchase, sale, or other transaction related to SCI tokens is undertaken at the sole discretion and risk of the participant. PoSciDonDAO does not assume responsibility for any loss, damages, or other consequences arising out of such transactions.
The SCI token is not and shall not be offered or sold to persons in the United States or individuals/entities on OFAC sanctioned lists. Further, this release does not constitute an offer to sell or a solicitation of an offer to buy any securities or financial instruments in any jurisdiction. Participants are strongly encouraged to conduct their own due diligence and seek independent advice from qualified legal, tax, or financial advisors before engaging with SCI tokens, blockchain technology, and digital assets generally. Participation in any token-related activities is subject to compliance with applicable laws, regulations, reporting, and eligibility requirements, including KYC/AML processes. PoSciDonDAO makes no guarantees or promises regarding the future performance, value, or regulatory compliance of the SCI tokens.
Contact
Marketing Representative
Ayat Abourashed
PoSciDonDAO Foundation
[email protected]
Source: Coincu
More From Market

USDT to BTC Exchange 2026: Best Rate With ChangeNOW and Alternatives
USDT to BTC in 2026: ChangeNOW, Swapzone, and StealthEX compared by rate spread, settlement time, and no-KYC limits. Fixed vs floating rate guide included.
Strait of Hormuz Shipping Attack Raises Oil Supply Fears
An attack on Strait of Hormuz shipping has renewed fears for oil supplies, according to unconfirmed reports, though the specific incident behind the headline re...
Block EPS Jumps 65%, Stock Falls Despite Strong Earnings
Block reported a 65% surge in earnings per share, yet its stock fell in the wake of the results, a disconnect that made market sentiment, rather than the headli...
BTC Price Warning: 4 Reasons Bitcoin Could Drop Next Week
This BTC price warning centers on a single decision level: Bitcoin has struggled to maintain the $65,000 mark, and a four-part downside setup has traders watchi...
Crypto Price Analysis July 24: ETH, XRP, ADA, BNB, HYPE
Ethereum is the only asset in this group with a defined weekly move, up 3% but pressing into resistance, according to CryptoPotato’s July 24 price analysis . Th...
FT report: London Stock Exchange plans round-the-clock trading
The London Stock Exchange is looking at moving to round-the-clock trading, the Financial Times reported . In practice, that would mean shares could be bought an...